Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Infectious Diseases of Poverty|June 19, 2025
Changes in influenza-associated excess mortality in China between 2012-2019 and 2020-2021: a population-based statistical modelling studyXiaowei Deng, Jiangmei Liu, Minghan Wang, et al.
Journal of Plant Physiology|April 15, 2026
Unveiling the multifaceted roles of crop secondary metabolites: From quality enhancement and stress resilience to molecular regulation and precision improvementHongwei Li, Hang Yan, Yingying Zhao, et al.
Organic Letters|April 22, 2026
Mechanochemical Rh(I)-Catalyzed C-N/C-C/C-H Triple Bond Activation of AmidesJin Zhang, Renjie Li, Yawei Zhu, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Icariside II Exerts Anti-Type 2 Diabetic Effect by Targeting PPARα/γ: Involvement of ROS/NF-κB/IRS1 Signaling PathwayYiqi Li, Yeli Li, Nana Chen, et al.
Antioxidants & Redox Signaling|March 28, 2020
Neuroprotective Effects of Trilobatin, a Novel Naturally Occurring Sirt3 Agonist from Lithocarpus polystachyus Rehd., Mitigate Cerebral Ischemia/Reperfusion Injury: Involvement of TLR4/NF-κB and Nrf2/Keap-1 SignalingJianmei Gao, Nana Chen, Na Li, et al.
Frontiers in Veterinary Science|October 10, 2022
Effects of Pgam1-mediated glycolysis pathway in Sertoli cells on Spermatogonial stem cells based on transcriptomics and energy metabolomicsXuejiao An, Qiao Li, Nana Chen, et al.
Applied Optics|February 3, 2016
Improved multiple-wavelength Brillouin-Raman fiber laser assisted by four-wave mixing with a micro-air cavityXuejiao Li, Liyong Ren, Xiao Lin, et al.
Frontiers in Pharmacology|June 9, 2020
Trilobatin Protects Against Aβ25-35-Induced Hippocampal HT22 Cells Apoptosis Through Mediating ROS/p38/Caspase 3-Dependent PathwayNana Chen, Jiao Wang, Yuqi He, et al.
Genomics|October 18, 2025
Genomic insights into dendrobine biosynthesis in the endophytic fungus Fusarium sp. DN689Nana Chen, Xinying Zhong, Hongwei Li, et al.
Journal of Cancer Research and Therapeutics|May 22, 2025
Microwave ablation combined with third-generation epidermal growth factor receptor-tyrosine kinase inhibitor treatment in EGFR-mutant advanced non-small cell lung cancerNana Chen, Xiaojing Tan, Cuiping Han, et al.
Pageof 11